AP-PA02
AP-PA02-201
Phase 2 mab completed
Quick answer
AP-PA02 for Non-cystic Fibrosis Bronchiectasis is a Phase 2 program (mab) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Armata Pharmaceuticals
- Indication
- Non-cystic Fibrosis Bronchiectasis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed